ASHLIE HEAD: Open Payments
NPI 1104452234 · RIVERVIEW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,020 in 57 payments from 19 companies in 2025. Trend: 2023 $442 · 2024 $1,085 · 2025 $1,020
Food & beverage: $1,020
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $207 |
| ABBVIE INC. | 7 | $157 |
| PFIZER INC. | 13 | $150 |
| Exact Sciences Corporation | 5 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $84 |
| Viatris Specialty LLC | 2 | $40 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Aimmune Therapeutics, Inc. | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $32 |
Products named: Wegovy, QULIPTA, NURTEC ODT, Cologuard Collection Kit, CAPLYTA, Rybelsus, PAXLOVID, YUPELRI.
Industry payments across MI — which companies pay providers there.
